Skip to main content

Activity of a Py-Im polyamide targeted to the estrogen response element.

Publication ,  Journal Article
Nickols, NG; Szablowski, JO; Hargrove, AE; Li, BC; Raskatov, JA; Dervan, PB
Published in: Molecular cancer therapeutics
May 2013

Pyrrole-imidazole (Py-Im) polyamides are a class of programmable DNA minor groove binders capable of modulating the activity of DNA-binding proteins and affecting changes in gene expression. Estrogen receptor alpha (ERα) is a ligand-activated hormone receptor that binds as a homodimer to estrogen response elements (ERE) and is a driving oncogene in a majority of breast cancers. We tested a selection of structurally similar Py-Im polyamides with differing DNA sequence specificity for activity against 17β-estadiol (E2)-induced transcription and cytotoxicity in ERα positive, E2-stimulated T47DKBluc cells, which express luciferase under ERα control. The most active polyamide targeted the sequence 5'-WGGWCW-3' (W = A or T), which is the canonical ERE half site. Whole transcriptome analysis using RNA-Seq revealed that treatment of E2-stimulated breast cancer cells with this polyamide reduced the effects of E2 on the majority of those most strongly affected by E2 but had much less effect on the majority of E2-induced transcripts. In vivo, this polyamide circulated at detectable levels following subcutaneous injection and reduced levels of ER-driven luciferase expression in xenografted tumors in mice after subcutaneous compound administration without significant host toxicity.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Molecular cancer therapeutics

DOI

EISSN

1538-8514

ISSN

1535-7163

Publication Date

May 2013

Volume

12

Issue

5

Start / End Page

675 / 684

Related Subject Headings

  • Xenograft Model Antitumor Assays
  • Transcription, Genetic
  • Response Elements
  • Oncology & Carcinogenesis
  • Nylons
  • Mice
  • Humans
  • Genes, Reporter
  • Gene Expression Regulation, Neoplastic
  • Gene Expression Profiling
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nickols, N. G., Szablowski, J. O., Hargrove, A. E., Li, B. C., Raskatov, J. A., & Dervan, P. B. (2013). Activity of a Py-Im polyamide targeted to the estrogen response element. Molecular Cancer Therapeutics, 12(5), 675–684. https://doi.org/10.1158/1535-7163.mct-12-1040
Nickols, Nicholas G., Jerzy O. Szablowski, Amanda E. Hargrove, Benjamin C. Li, Jevgenij A. Raskatov, and Peter B. Dervan. “Activity of a Py-Im polyamide targeted to the estrogen response element.Molecular Cancer Therapeutics 12, no. 5 (May 2013): 675–84. https://doi.org/10.1158/1535-7163.mct-12-1040.
Nickols NG, Szablowski JO, Hargrove AE, Li BC, Raskatov JA, Dervan PB. Activity of a Py-Im polyamide targeted to the estrogen response element. Molecular cancer therapeutics. 2013 May;12(5):675–84.
Nickols, Nicholas G., et al. “Activity of a Py-Im polyamide targeted to the estrogen response element.Molecular Cancer Therapeutics, vol. 12, no. 5, May 2013, pp. 675–84. Epmc, doi:10.1158/1535-7163.mct-12-1040.
Nickols NG, Szablowski JO, Hargrove AE, Li BC, Raskatov JA, Dervan PB. Activity of a Py-Im polyamide targeted to the estrogen response element. Molecular cancer therapeutics. 2013 May;12(5):675–684.

Published In

Molecular cancer therapeutics

DOI

EISSN

1538-8514

ISSN

1535-7163

Publication Date

May 2013

Volume

12

Issue

5

Start / End Page

675 / 684

Related Subject Headings

  • Xenograft Model Antitumor Assays
  • Transcription, Genetic
  • Response Elements
  • Oncology & Carcinogenesis
  • Nylons
  • Mice
  • Humans
  • Genes, Reporter
  • Gene Expression Regulation, Neoplastic
  • Gene Expression Profiling